A Montreal Cognitive Assessment (MoCA) score below 21 out of 30 is the threshold most strongly linked to Parkinson's disease dementia (PDD), identifying it with 81% sensitivity and 95% specificity in the test's original validation study. The MoCA is a 10-minute, 30-point screening tool covering memory, attention, language and visuospatial skills, and a low score flags a cognitive problem serious enough to need a full diagnostic workup, not a diagnosis by itself. That distinction matters because the same test uses a different cutoff for a milder condition. According to the original MoCA validation study, scoring below 26 out of 30 points to PD-related mild cognitive impairment (PD-MCI) rather than dementia, so where a person's score falls on that scale changes what it means for daily function and care planning.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the MoCA Score Ranges Actually Mean
- Why the Same Score Can Mean Different Things in Different Patients
- Which Skills on the Test Predict Decline — and Why Memory Isn't the Whole Story
- How Likely Is Dementia After a Parkinson's Diagnosis — and How Soon?
- Frequently Asked Questions
What the MoCA Score Ranges Actually Mean
The MoCA is scored out of 30 points, with lower scores indicating worse performance across memory, attention, language, and visuospatial tasks. In the test's founding validation work, a score below 21 best separated people with Parkinson's disease dementia from those without it, catching 81% of true PDD cases while correctly clearing 95% of people who did not have it, as reported in the Neurology validation study. A score between 21 and 26 sits in a different zone. That range aligns more with PD-MCI, a state where thinking skills have measurably declined from a person's baseline but daily independence is still intact.
The two conditions require different conversations with a care team: PD-MCI calls for monitoring and risk reduction, while a PDD-range score calls for a fuller dementia evaluation. No single score applies equally to everyone. A Brazilian Portuguese-language validation of the MoCA found that a cutoff of 22.5 best separated normal cognition from PDD, with 85.5% sensitivity and 71.1% specificity, while a lower cutoff of 17.5 worked better for distinguishing PDD from PD-MCI, according to a MoCA validation published on PMC. The number that matters is the one a clinician applies against the population and tools they actually used.
Why the Same Score Can Mean Different Things in Different Patients
Cutoff scores shift depending on the population tested, which is why a single "below 21" rule does not travel perfectly across every clinic or country. A study of 616 Chinese Parkinson's patients, diagnosed using the same Movement Disorder Society criteria, found the best-performing MoCA cutoff for dementia was 23 — with sensitivity and specificity of only 70% and 77%, both lower than the original study's figures, as detailed in a PMC-published cohort analysis. That gap shows the dementia threshold is not fixed; it moves with language, education level, and cultural familiarity with the test's tasks. This is also why the MoCA score functions as a screening flag, not a stand-alone verdict.
The Movement Disorder Society Task Force's clinical diagnostic criteria for PDD require dementia to emerge in the context of established Parkinson's disease, with impairment spanning attention, memory, executive function, and visuospatial skills — often alongside apathy or hallucinations. Per the Task Force's published criteria, no biomarker or test score substitutes for that clinical judgment. A MoCA number is the trigger for a fuller evaluation, not the evaluation itself. For families comparing a loved one's score against an article or a different clinic's chart, this variability explains why two sources can list different cutoffs without either being wrong. The number to act on is the one the evaluating clinician is using for that specific patient's testing conditions.
Which Skills on the Test Predict Decline — and Why Memory Isn't the Whole Story
The MoCA's total score hides which specific skills are driving a decline, and those sub-skills carry their own predictive weight. In an analysis of 529 cognitive assessments from 164 Parkinson's patients with MCI, performance on visuospatial tasks, attention, language, and orientation — not delayed memory recall — best predicted who would go on to develop dementia, according to a movement disorders conference report. This runs counter to the common assumption that memory loss is the primary warning sign in Parkinson's-related cognitive decline. That finding has a practical use: a person whose memory recall stays relatively strong but who struggles with copying shapes, naming objects, or tracking the date on the MoCA may be at higher risk than the total score alone suggests.
A clinician reviewing the sub-scores, not just the final number out of 30, gets a clearer picture of where the decline is concentrated and how fast it may be moving toward dementia. A separate large study reinforces that different tools catch different transitions. In a 2024 Italian multicenter study of 1,780 Parkinson's patients, the MoCA was most useful for identifying the earlier shift from normal cognition to PD-MCI, at a cutoff of 22 or below, while the older Mini-Mental State Examination (MMSE) at 24 or below was the stronger predictor specifically for conversion to full dementia, per a medRxiv summary of the Italian cohort. The two screening tools serve complementary roles rather than interchangeable ones, which is a reason a care team might use both over time.
How Likely Is Dementia After a Parkinson's Diagnosis — and How Soon?
How a MoCA score should be weighed also depends on how far into the disease a person is, because dementia risk compounds heavily over time. An 8-year prospective Norwegian cohort of 224 Parkinson's patients found cumulative dementia prevalence reached 78.2% by the end of follow-up, with baseline hallucinations and a mixed tremor/akinetic subtype of Parkinson's as significant predictors, according to an Archives of Neurology study summarized by Alzforum. The study's authors noted that losses to follow-up may mean the true long-term rate is even higher than reported. More recent data suggests a slower, later-arriving trajectory for many patients today.
A 2024 analysis of the Penn Parkinson's cohort found cumulative dementia probability was about 27% at 10 years, 50% at 15 years, and 74% at 20 years of disease duration, with a median time to dementia of 15 years, as reported in a Neurology study. A companion cohort, the Parkinson's Progression Markers Initiative (PPMI), showed even lower 10-year dementia rates of 9% to 15%, depending on how dementia was defined in that analysis. The gap between these two sets of numbers is likely explained by decades of improvement in Parkinson's treatment and monitoring, along with differences in how each cohort tracked and defined dementia onset. For a person newly diagnosed with Parkinson's today, these more recent figures suggest a longer window before dementia risk rises sharply — information worth raising directly with a neurologist when discussing what a given MoCA score means for long-term planning.
- A MoCA score below 21 is the figure most associated with Parkinson's disease dementia in the test's founding validation study.
- A score of 21-26 more often reflects PD-MCI, a milder state that still allows independent daily function.
- Visuospatial, attention, language, and orientation sub-scores — not memory recall — carry the strongest signal for predicting who progresses to dementia.
- Cumulative dementia risk in Parkinson's ranges widely by cohort and era, from roughly 27% at 10 years in a recent U.S. study to 78% by 8 years in an earlier Norwegian one.
Frequently Asked Questions
Can a MoCA score alone diagnose Parkinson's disease dementia?
No. The Movement Disorder Society Task Force's criteria require dementia to be confirmed through clinical evaluation across multiple cognitive domains; a MoCA score only flags the need for that evaluation.
Is the MoCA better than the MMSE for Parkinson's cognitive screening?
They serve different purposes. A 2024 Italian cohort study found the MoCA was stronger for catching the earlier shift to mild cognitive impairment, while the MMSE was the stronger predictor specifically for conversion to dementia.
Does a stable MoCA score over several visits rule out future dementia risk?
Not necessarily. Sub-scores in visuospatial, attention, language, and orientation tasks have predicted later dementia even before the total score dropped sharply, so tracking domain-level performance matters as much as the overall number.
